PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
|Articles|February 2, 2022
- Pharmaceutical Technology, February 2022 Issue
- Volume 46
- Issue 2
- Pages: 12
Environmental Monitoring Plates
Author(s)Pharmaceutical Technology Editors
Thermo Fisher Scientific's Triple Wrap Plates possess a unique Vapour-phase Hydrogen Peroxide (VHP) indicator for enhanced sterility and complete clean room and isolator confidence.
Thermo Fisher Scientific’s Triple Wrap Plates are a range of culture media products designed for environmental monitoring in the pharmaceutical industry. They feature 2D barcodes for full traceability and supply chain integrity, secure fit lids, advanced, clear, triple-layer protection, and a unique Vapour-phase Hydrogen Peroxide (VHP) indicator for enhanced sterility and complete clean room and isolator confidence.
In addition to the integrated VHP indicator, the product comes with new polypropylene packaging, which together enable sanitization of containers for enhanced sterility assurance. The plates are available in standard plates for passive and active air sampling applications and 55 mm contact plates for the microbiological testing of surfaces and personnel.
Articles in this issue
over 4 years ago
Analysis of mRNA Therapeutics and Vaccinesover 4 years ago
What’s Next for COVID-19 Vaccines and Variants?over 4 years ago
Synthesis, Extraction, and Purification of Cannabinoidsover 4 years ago
Accelerating Workforce Training on Single-Use Technologiesover 4 years ago
How to Effectively Implement Pharma 4.0 Technologiesover 4 years ago
Serialization and Aggregation from a Manufacturing Perspectiveover 4 years ago
Driving Consistency in Validation Managementover 4 years ago
What’s in Your Quality Manual?Related to this article
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
AI can turn medical device risk management into a continuous signal.
Sanofi will transfer 20 mature medicines and three manufacturing sites to Cheplapharm for a 26.4% equity stake, closing by Q3 2027.
On PharmTech.com this week, coverage of upcoming events continued, experts continued to discuss the use of AI in pharma, and validation in oral solid dosage product production was emphasized.
Christy Owings, Thermo Fisher, on why early supply chain partnership and site visits prevent costly eCOA and clinical trial delays.
This article explores the historical use of silicone oil in the performance of primary drug product packaging; design of experiment test results for selection of the cleaning agent and CCPs; assessment of visible residue limits and Fourier-transform infrared spectroscopy surface analysis; and setting health-based exposure limits for silicone oil using a non-uniform distribution model, and a previously published permitted daily exposure.